Stay updated on Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Sign up to get notified when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.

Latest updates to the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed study descriptions and criteria for a Phase 2 clinical trial on copper Cu 64 PSMA I&T injection for metastatic prostate cancer, while a new version number has been added.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for January 24, 2025, while a date for March 25, 2025, has been removed.SummaryDifference0.8%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cu-64-PSMA-I&T PET in Metastatic Prostate Cancer Clinical Trial page.